The following video is part of our "Motley Fool Conversations" series, in which consumer goods editor/analyst Austin Smith and industrials editor/analyst Brendan Byrnes discuss topics across the investing world.
In today's edition, Brendan and Austin talk about one of the best buy-and-hold stocks out there: Johnson & Johnson. The accolades just keep stacking up for a company like this. It has a high dividend yield and highly sustainable payout ratio, and it's well-diversified across three major segments. Because of its size and diversity, Johnson & Johnson can withstand far more market turmoil than many of its competitors.
Austin Smith owns shares of Pfizer. Brendan Byrnes has no positions in the stocks mentioned above. The Motley Fool owns shares of Johnson & Johnson. Motley Fool newsletter services recommend Johnson & Johnson, Pfizer, and Procter & Gamble. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Does a Strong Start Make 2018 a Sure Winner for Stocks?
Find out whether the so-called "January effect" is real.
Meet the 2018 Dogs of the Dow
Learn the basics of this simple dividend-investing strategy.
The Dow's Worst Day in 2017
Even with big gains, there were some scary times for the average.